Gene: ZNF616
Official Full Name: zinc finger protein 616provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23797 | ZNF616 Knockout cell line (HeLa) | Human | ZNF616 | 1:3~1:6 | Negative | Online Inquiry |
KO23798 | ZNF616 Knockout cell line (HCT 116) | Human | ZNF616 | 1:2~1:4 | Negative | Online Inquiry |
KO23799 | ZNF616 Knockout cell line (HEK293) | Human | ZNF616 | 1:3~1:6 | Negative | Online Inquiry |
KO23800 | ZNF616 Knockout cell line (A549) | Human | ZNF616 | 1:3~1:4 | Negative | Online Inquiry |
ZNF616 Gene Knockout Cell Lines represent a cutting-edge tool in genetic research and experimental biology, specifically designed to facilitate the study of the ZNF616 gene's functional role within cellular processes. These cell lines have been engineered using advanced CRISPR/Cas9 technology to create stable knockout models that completely inhibit the expression of the ZNF616 gene. This targeted gene disruption allows for precise investigations into the gene's involvement in various biological pathways, particularly those related to gene regulation, cell differentiation, and disease mechanisms.
The key function of ZNF616 Gene Knockout Cell Lines lies in their ability to mimic loss-of-function mutations that researchers are interested in studying. By observing the phenotypic changes and molecular responses in these knockout cells compared to wild-type controls, scientists can elucidate the biological significance of ZNF616 and its potential implications in disease susceptibility, including cancer and neurological disorders.
From a scientific standpoint, these knockout cell lines serve as invaluable assets in both research and clinical contexts. They enable the validation of targets for therapeutic intervention, the exploration of gene-function relationships, and the development of novel diagnostic tools. The availability of such models speeds up the pace of discovery and enhances the reproducibility of experimental outcomes.
Compared to alternative products, the ZNF616 Gene Knockout Cell Lines provide several unique advantages. They are characterized by their high specificity and efficiency in gene editing, reducing the risk of off-target effects that can confound experimental results. Additionally, our product comes with robust quality assurance and detailed characterization data, ensuring that users can trust in the integrity of their results.
For researchers, clinicians, and pharmaceutical developers, investing in ZNF616 Gene Knockout Cell Lines offers an opportunity to deepen their understanding of genetic influence on health and disease, optimize drug development pathways, and pioneer new treatment strategies. Our company prides itself on expertise in genetic engineering and a commitment to providing high-quality biological products that empower scientific innovation and discovery in the life sciences field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.